Evidence map›Paper›PMID 19706757›Full record

SynthesisCancer research2009

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

Mariana C Stern, Jie Lin, Jonine D Figueroa, Karl T Kelsey, Anne E Kiltie, Jian-Min Yuan, Giuseppe Matullo, Tony Fletcher, Simone Benhamou, Jack A Taylor and 39 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Cancer research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 10 pooled it
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 10 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  10. Pooled it
  11. Review
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Risk Factors Associated with Urothelial Bladder Cancer.International journal of environmental research and public health · 2024
    Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors at 20 institutions in 10 countries.

Mariana C SternDepartment of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089, USA. stern_m@ccnt.usc.edu
Jie Lin
Jonine D Figueroa
Karl T Kelsey
Anne E Kiltie
Jian-Min Yuan
Giuseppe Matullo
Tony Fletcher
Simone Benhamou
Jack A Taylor
Donatella Placidi
Zuo-Feng Zhang
Gunnar Steineck
Nathaniel Rothman
Manolis Kogevinas
Debra Silverman
Nuria Malats
Stephen Chanock
Xifeng Wu
Margaret R Karagas
Angeline S Andrew
Heather H Nelson
D Timothy Bishop
Sei Chung Sak
Ananya Choudhury
Jennifer H Barrett
Faye Elliot
Román Corral
Amit D Joshi
Manuela Gago-Dominguez
Victoria K Cortessis
Yong-Bing Xiang
Yu-Tang Gao
Paolo Vineis
Carlotta Sacerdote
Simonetta Guarrera
Silvia Polidoro
Alessandra Allione
Eugen Gurzau
Kvetoslava Koppova
Rajiv Kumar
Peter Rudnai
Stefano Porru
Angela Carta
Marcello Campagna
Cecilia Arici
Sung Shim Lani Park
Montserrat Garcia-Closas
International Consortium of Bladder Cancer
National Cancer Institute · USUniversity of Brescia · ITUniversity of Southern California · USInstitute for Scientific Interchange · ITCancer Research UK · GBUniversity of Leeds · GBShanghai Cancer Institute · CNThe University of Texas MD Anderson Cancer Center · USUniversity of California, Los Angeles · USUniversity of Turin · ITCenter for Research in Environmental Epidemiology · ESCommunity Health Center · USHeidelberg University · DEInserm · FRKarolinska Institutet · SELondon School of Hygiene & Tropical Medicine · GBNational Institute of Environmental Health Sciences · USOrszagos Kornyezetegeszsegugyi Intezet · HUSpanish National Cancer Research Centre · ESUniversity of Minnesota Medical Center · US

Funding

VARIATION IN BIOACCUMULATION AND BIOMAGNIFICATION OF METALS IN NORTHERN US LAKESP42ES007373 · NIEHS · DARTMOUTH COLLEGE · PI CHEN, CELIA Y · 1995 to 2019
$52.0M
Molecular Epidemiology Studies of Occupational and Environmental ExposuresZIACP010121 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ROTHMAN, NATHANIEL · 2009 to 2025
$23.5M
NONMELANOMA SKIN CANCER IN NEW HAMPSHIRER01CA057494 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1993 to 2015
$10.9M
Genetic Susceptibility And The Environment In Cancer RiskZIAES049033 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI TAYLOR, JACK A · 2009 to 2022
$7.7M
Silencing of Apoptotic Pathways in TCC by DNA MethylationP01CA086871 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JONES, PETER A · 2002 to 2006
$6.8M
UCLA CANCER EPIDEMIOLOGY TRAINING PROGRAMT32CA009142 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1986 to 2024
$6.3M
Markers of Genetic Susceptibility to Bladder CancerR01CA074880 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WU, XIFENG · 1999 to 2008
$3.1M
Genetic Instability & Risk for Esophageal CarcinomaR01CA111922 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WU, XIFENG · 2008 to 2012
$2.9M
GENETIC & ENVIRONMENTAL RISK FACTORS FOR BLADDER CANCERR01CA114665 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PIKE, MALCOLM C · 2006 to 2009
$2.2M
Bladder Cancer Prognostic IndicatorsK07CA102327 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2005 to 2009
$819k
Comprehensive Assessment of Bladder Cancer Genetic SusceptibilityR03CA121382 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2006 to 2007
$158k
MOLECULAR EPIDEMIOLOGY OF BLADDER CANCERR01ES006718 · NIEHS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI ZHANG, ZUO-FENG · 1993 to 1995
–
Cancer Research UK 10589Cancer Research UK A4994Intramural NIH HHSNCI NIH HHS 1P01CA86871NCI NIH HHS 1R01CA114665NCI NIH HHS CA09142NCI NIH HHS K07 CA102327NCI NIH HHS N02 CP011015NCI NIH HHS P01 CA086871NCI NIH HHS R01 CA057494NCI NIH HHS R01 CA074880NCI NIH HHS R01 CA111922NCI NIH HHS R01 CA114665NCI NIH HHS R01CA57494NCI NIH HHS R01 CA74880NCI NIH HHS R03 CA121382NCI NIH HHS T32 CA009142NIEHS NIH HHS ES06718NIEHS NIH HHS P42 ES007373
6 · The paper itself

Abstract

Tobacco smoking is the most important and well-established bladder cancer risk factor and a rich source of chemical carcinogens and reactive oxygen species that can induce damage to DNA in urothelial cells. Therefore, common variation in DNA repair genes might modify bladder cancer risk. In this study, we present results from meta-analyses and pooled analyses conducted as part of the International Consortium of Bladder Cancer. We included data on 10 single nucleotide polymorphisms corresponding to seven DNA repair genes from 13 studies. Pooled analyses and meta-analyses included 5,282 cases and 5,954 controls of non-Latino white origin. We found evidence for weak but consistent associations with ERCC2 D312N [rs1799793; per-allele odds ratio (OR), 1.10; 95% confidence interval (95% CI), 1.01-1.19; P = 0.021], NBN E185Q (rs1805794; per-allele OR, 1.09; 95% CI, 1.01-1.18; P = 0.028), and XPC A499V (rs2228000; per-allele OR, 1.10; 95% CI, 1.00-1.21; P = 0.044). The association with NBN E185Q was limited to ever smokers (interaction P = 0.002) and was strongest for the highest levels of smoking dose and smoking duration. Overall, our study provides the strongest evidence to date for a role of common variants in DNA repair genes in bladder carcinogenesis.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideDNA-Binding ProteinsDNA RepairFemaleHumansMaleRacial GroupsRiskRisk FactorsSmokingUrinary Bladder NeoplasmsXeroderma Pigmentosum Group D ProteinDNA-Binding ProteinsXeroderma Pigmentosum Group D ProteinXPC protein, human

Identifiers

PMID19706757
PMCPMC2782435
OpenAlexW2150791133

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.